skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8838

Aripiprazole for late-life schizophrenia

Review

(2495) Views  (645) Full article downloads

Authors: Jeffrey Rado, Philip G Janicak

Published Date August 2010 Volume 2010:5 Pages 253 - 258
DOI: http://dx.doi.org/10.2147/CIA.S9398

Jeffrey Rado, Philip G Janicak

Psychiatric Clinical Research Center, Rush University Medical Center, Chicago, IL, USA

Abstract: Antipsychotics are frequently used in elderly patients to treat a variety of conditions, including schizophrenia. While extensively studied for their impact in younger ­populations, there is comparatively limited evidence about the effectiveness of these agents in older patients. Further complicating this situation are the high co-morbidity rates (both psychiatric and ­medical) in the elderly; age-related changes in pharmacokinetics leading to a heightened proclivity for adverse effects; and the potential for multiple, clinically relevant drug interactions. With this background in mind, we review diagnostic and treatment-related issues specific to elderly patients suffering from schizophrenia and other psychotic conditions, focusing on the potential role of aripiprazole.

Keywords: aripiprazole, schizophrenia, elderly, dopamine partial antagonist







Readers of this article also read:

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Efficacy and safety of risperidone long-acting injection in elderly people with schizophrenia
"If we only got a chance.” Barriers to and possibilities for a more health-promoting health service
Levels of circulating homocysteine, vitamin B6, vitamin B12, and folate in different types of open-angle glaucoma
Assessment and management of nutrition in older people and its importance to health
Advantages of dietary, exercise-related, and therapeutic interventions to prevent and treat sarcopenia in adult patients: an update
Once-monthly paliperidone injection for the treatment of schizophrenia
Elderly quality of life impacted by traditional chinese medicine techniques
Late-life depression with comorbid cognitive impairment and disability: nonpharmacological interventions
Paliperidone extended-release: does it have a place in antipsychotic therapy?